IP Library › Assignment 036291/0269
Patent Assignment
Reel/Frame 036291/0269

Assignment of Assignor's Interest

Recorded: 2015-08-10 Pages: 3
Assignors
SCHOLZ, WOLFGANG
Executed: 2015-08-07
SAWADA, RITSUKO
Executed: 2015-08-07
Assignee
MABVAX THERAPEUTICS, INC.
11588 SORRENTO VALLEY ROAD, SUITE 20, SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
Human Monoclonal Antibodies to Ganglioside GD2
Patent: 9,856,324 →
Application: 14/730,036 →
Publication: US 2015/0353645
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 15, 2015
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 037296/0710 →
Security Interest Jul 12, 2018
From: MABVAX THERAPEUTICS HOLDINGS, INC.; MABVAX THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS A LENDER
Reel/Frame 046337/0252 →
Assignment of Assignor's Interest Jun 26, 2019
From: MABVAX THERAPEUTICS, INC.
To: BIONTECH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 049586/0362 →
Change of Address in Recorded Assignment Jan 31, 2020
From: MABVAX THERAPEUTICS, INC.
To: BIONTECH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 051762/0305 →
Assignment of Assignor's Interest Sep 18, 2025
From: BIONTECH RESEARCH AND DEVELOPMENT, INC.
To: BIONTECH SE
Reel/Frame 072302/0591 →